Cidara Therapeutics Stock (NASDAQ: CDTX) stock price, news, charts, stock research, profile.
Open | $11.18 |
Close | - |
Volume / Avg. | 12.98K / 27.83K |
Day Range | $11.00 - $11.28 |
52 Wk Range | 10.00 - 24.40 |
Market Cap | $79.32M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 1.19% |
Days to Cover | 3.21 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cidara Therapeutics (NASDAQ:CDTX) through any online brokerage.
Other companies in Cidara Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB), Armata Pharmaceuticals (AMEX:ARMP) and Gritstone Bio (NASDAQ:GRTS).
Cidara Therapeutics has a consensus price target of $29.67.
The stock price for Cidara Therapeutics (NASDAQ: CDTX) is $11 last updated September 23, 2024 at 3:57 PM EDT.
There are no upcoming dividends for Cidara Therapeutics.
Cidara Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Cidara Therapeutics.
Cidara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.